Sponsors

Tepnel extends licence agreement with Luminex

  •  

Tepnel Life Sciences has agreed an extension of the licence with Luminex for access to the Luminex xMAP platform. The Luminex xMAP technology is incorporated in TepnelÆs innovative molecular diagnostics products.

Tepnel’s LifeMatch products are used for the measurement and detection of human leucocyte antigen (HLA) markers, which are used in the field of bone marrow and solid organ transplantation. These products permit the rapid analysis of a donor’s HLA type to determine if they are a potential match to a patient awaiting transplantation.

Tepnel develops highly multiplexed DNAand protein-based assays and user-friendly software for its successful LifeMatch product line. The Luminex technology allows Tepnel Lifecodes users to analyse up to 100 simultaneous reactions on a single patient sample.

www.tepnel.com

Other News

Novel AI model detects gene mutations and predicts biomarkers

News

Aug 18, 2026
WFD applied to the observation of bacterial ultrastructure

News

Aug 18, 2026
New antibiotic mechanism triggers hope for new treatments in fight against resistance

News

Aug 18, 2026
Fridge-free vaccine could reach millions more worldwide

News

Aug 18, 2026
RSV maternal vaccine sees newborn ICU admissions drop 50%

News

Aug 18, 2026
New research reveals more on mānuka honey’s antimicrobial properties

News

Aug 17, 2026
OGT marks start of CytoCell IVDR transition with new prenatal FISH probe kits

News

Aug 17, 2026
Leica Biosystems expands digital pathology capabilities

News

Aug 14, 2026
Manchester’s £60 million laboratory and workspace development completed

News

Aug 13, 2026

Latest Issues

Launch Diagnostics Ltd

Launch Diagnostics provides complete pathology solutions with a comprehensive portfolio of high-quality diagnostic reagents and instrumentation from world leading manufacturers to the Health Services of the United Kingdom. Our associated companies also provide solutions to France, Belgium, and Luxemburg through Launch Diagnostics SAS and to the...

Learn more »

ECP 2026 - 38th European Congress of Pathology

Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026

UK NEQAS Parasitology Symposium

UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026

UKHSA Conference 2026

Manchester Central, Manchester, M2 3GX
22-23 September, 2026

Cardiac Marker Dialogues

Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026

46th European Congress of Cytology

Hilton Antwerp Old Town, Antwerp
4-7 October, 2026